- call +1-201-465-4211
- email sales@mrinsights.biz
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers. Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is used to describe the acute onset of symptomatic hepatitis. Symptoms include changes I appetite, dry mouth, yellowing of skin or eyes, weight loss, fever and fatigue. Sometime alcoholic hepatitis could get serious conditions include fluid buildup in the abdomen, confusion or brain fog and bleeding in esophagus or stomach. Treatment for alcoholic hepatitis involves therapies and drinking cessation to ease the sign and symptoms of liver damage. Corticosteroids are the current main treatment for alcoholic hepatitis in patients who do not have contraindication for steroid treatment. Corticosteroids are the medications have shown short-term benefits in increasing survival of certain people suffer with alcoholic hepatitis. Pentoxifylline is recommend to patients who can’t take corticosteroids. Studies indicate that pentoxifylline might not be effective for people with mild alcoholic hepatitis or people who have not respond to steroid treatment.
Scope of the Report:
This report studies the Alcoholic Hepatitis Therapeutic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Alcoholic Hepatitis Therapeutic market by product type and applications/end industries.
The global alcoholic hepatitis therapeutics market is expected to witness a favorable growth during the forecast period. Increasing incidence of liver diseases and high success rate of pipeline drugs are the major factors which increase global alcoholic hepatitis market. Moreover high adoption rate for novel therapeutic products and increasing prevalence of alcoholic liver disease are some other factors that are expected to fuel the demand of global alcoholic hepatitis market. Global alcoholic hepatitis market shows potential to be expanding and lucrative field due to increasing merger and acquisitions among pharmaceutical companies to develop advance therapies for treating liver diseases. Furthermore, increased focus on retaining best quality of life is one the factor contributing to the growth of the market. However increasing health care expenditure, stringent reimbursement policies and high development cost are some factors that might hinder the growth of alcoholic hepatitis therapeutics market in forecast period.
The global Alcoholic Hepatitis Therapeutic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Alcoholic Hepatitis Therapeutic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Alkermes
Conatus pharmaceuticals
Dainippon sumitomo pharma
Generon corporation
Immuron limited
Lupin Laboratories
Intercept Pharmaceuticals
Teva Pharmaceuticals
Sanofi-Aventis
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Monoclonal Antibodies
Caspase Protease Inhibitor
Corticosteroids
Hemorheologic Agents
Anabolic Steroids
Hepatotropic Hormones
Sulfhydryl Agents
Others
Market Segment by Applications, can be divided into
Hospitals and Clinics
Research and Development
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Alcoholic Hepatitis Therapeutic Market Overview
1.1 Product Overview and Scope of Alcoholic Hepatitis Therapeutic
1.2 Classification of Alcoholic Hepatitis Therapeutic by Types
1.2.1 Global Alcoholic Hepatitis Therapeutic Revenue Comparison by Types (2017-2023)
1.2.2 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Types in 2017
1.2.3 Monoclonal Antibodies
1.2.4 Caspase Protease Inhibitor
1.2.5 Corticosteroids
1.2.6 Hemorheologic Agents
1.2.7 Anabolic Steroids
1.2.8 Hepatotropic Hormones
1.2.9 Sulfhydryl Agents
1.2.10 Others
1.3 Global Alcoholic Hepatitis Therapeutic Market by Application
1.3.1 Global Alcoholic Hepatitis Therapeutic Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and Clinics
1.3.3 Research and Development
1.4 Global Alcoholic Hepatitis Therapeutic Market by Regions
1.4.1 Global Alcoholic Hepatitis Therapeutic Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Alcoholic Hepatitis Therapeutic Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Alcoholic Hepatitis Therapeutic Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alcoholic Hepatitis Therapeutic Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Alcoholic Hepatitis Therapeutic Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alcoholic Hepatitis Therapeutic Status and Prospect (2013-2023)
1.5 Global Market Size of Alcoholic Hepatitis Therapeutic (2013-2023)
2 Manufacturers Profiles
2.1 Alkermes
2.1.1 Business Overview
2.1.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Alkermes Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.2 Conatus pharmaceuticals
2.2.1 Business Overview
2.2.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Conatus pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dainippon sumitomo pharma
2.3.1 Business Overview
2.3.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dainippon sumitomo pharma Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.4 Generon corporation
2.4.1 Business Overview
2.4.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Generon corporation Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.5 Immuron limited
2.5.1 Business Overview
2.5.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Immuron limited Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.6 Lupin Laboratories
2.6.1 Business Overview
2.6.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lupin Laboratories Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Intercept Pharmaceuticals
2.7.1 Business Overview
2.7.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Intercept Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.8 Teva Pharmaceuticals
2.8.1 Business Overview
2.8.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Teva Pharmaceuticals Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi-Aventis
2.9.1 Business Overview
2.9.2 Alcoholic Hepatitis Therapeutic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi-Aventis Alcoholic Hepatitis Therapeutic Revenue, Gross Margin and Market Share (2016-2017)
3 Global Alcoholic Hepatitis Therapeutic Market Competition, by Players
3.1 Global Alcoholic Hepatitis Therapeutic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Alcoholic Hepatitis Therapeutic Players Market Share
3.2.2 Top 10 Alcoholic Hepatitis Therapeutic Players Market Share
3.3 Market Competition Trend
4 Global Alcoholic Hepatitis Therapeutic Market Size by Regions
4.1 Global Alcoholic Hepatitis Therapeutic Revenue and Market Share by Regions
4.2 North America Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
4.3 Europe Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
4.5 South America Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
5 North America Alcoholic Hepatitis Therapeutic Revenue by Countries
5.1 North America Alcoholic Hepatitis Therapeutic Revenue by Countries (2013-2018)
5.2 USA Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
5.3 Canada Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
5.4 Mexico Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
6 Europe Alcoholic Hepatitis Therapeutic Revenue by Countries
6.1 Europe Alcoholic Hepatitis Therapeutic Revenue by Countries (2013-2018)
6.2 Germany Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
6.3 UK Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
6.4 France Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
6.5 Russia Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
6.6 Italy Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue by Countries
7.1 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue by Countries (2013-2018)
7.2 China Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
7.3 Japan Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
7.4 Korea Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
7.5 India Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
8 South America Alcoholic Hepatitis Therapeutic Revenue by Countries
8.1 South America Alcoholic Hepatitis Therapeutic Revenue by Countries (2013-2018)
8.2 Brazil Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
8.3 Argentina Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
8.4 Colombia Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Alcoholic Hepatitis Therapeutic by Countries
9.1 Middle East and Africa Alcoholic Hepatitis Therapeutic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
9.3 UAE Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
9.4 Egypt Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
9.6 South Africa Alcoholic Hepatitis Therapeutic Revenue and Growth Rate (2013-2018)
10 Global Alcoholic Hepatitis Therapeutic Market Segment by Type
10.1 Global Alcoholic Hepatitis Therapeutic Revenue and Market Share by Type (2013-2018)
10.2 Global Alcoholic Hepatitis Therapeutic Market Forecast by Type (2018-2023)
10.3 Monoclonal Antibodies Revenue Growth Rate (2013-2023)
10.4 Caspase Protease Inhibitor Revenue Growth Rate (2013-2023)
10.5 Corticosteroids Revenue Growth Rate (2013-2023)
10.6 Hemorheologic Agents Revenue Growth Rate (2013-2023)
10.7 Anabolic Steroids Revenue Growth Rate (2013-2023)
10.8 Hepatotropic Hormones Revenue Growth Rate (2013-2023)
10.9 Sulfhydryl Agents Revenue Growth Rate (2013-2023)
10.10 Others Revenue Growth Rate (2013-2023)
11 Global Alcoholic Hepatitis Therapeutic Market Segment by Application
11.1 Global Alcoholic Hepatitis Therapeutic Revenue Market Share by Application (2013-2018)
11.2 Alcoholic Hepatitis Therapeutic Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Research and Development Revenue Growth (2013-2018)
12 Global Alcoholic Hepatitis Therapeutic Market Size Forecast (2018-2023)
12.1 Global Alcoholic Hepatitis Therapeutic Market Size Forecast (2018-2023)
12.2 Global Alcoholic Hepatitis Therapeutic Market Forecast by Regions (2018-2023)
12.3 North America Alcoholic Hepatitis Therapeutic Revenue Market Forecast (2018-2023)
12.4 Europe Alcoholic Hepatitis Therapeutic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Alcoholic Hepatitis Therapeutic Revenue Market Forecast (2018-2023)
12.6 South America Alcoholic Hepatitis Therapeutic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Alcoholic Hepatitis Therapeutic Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Alcoholic Hepatitis Therapeutic Picture
Table Product Specifications of Alcoholic Hepatitis Therapeutic
Table Global Alcoholic Hepatitis Therapeutic and Revenue (Mil
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
